Tuesday, January 12, 2016

Buy - Morepen Labs

Here is a small cap recommendation from Smart Investor 

Background :

Morepen Laboratories Limited is an India-based pharmaceutical company. The Company operates through four segments; they are Active Pharmaceutical Ingredients (API), Domestic Formulations, Diagnostics and Over the Counter (OTC). The API segment has developed new products like Sitagliptin Phosphate, Rosuvastatin Calcium, Olmesartan Medoxomil and Aliskiren in the Research and Development laboratory. 

The Domestic Formulations segment markets over 100 branded formulations in 8 major therapeutic segments. The Diagnostics segment markets under its own brand name Clinical and Home Health devices and Blood Banking machines. The OTC segment market brands like Burnol ,Lemolate, Sat-Isabgol, Option -72, Head-X, Fever-X , C- Candy and other Over the Counter (OTC) products. The Company has 3 manufacturing facilities, for manufacture of API, formulations and OTC products with international standings.

Source : Reuters

Trend : 

Short term : Down
Medium term : Up
Long term : Up

Return ratios :

The stock has given a steady returns and created wealth to the investors

1 month =  25%
3 months = 200%
6 months = 300%
12 months = 360%

Recommendation :

There has been turn around in fortunes of this company and one can expect decent up move from here.  Buy around Rs.30 levels and hold for a target of Rs.60 holding period of 12 months


Smart Investor

No.24 Pattamal Plaza
3rd Cross Kammanahalli

Mobile / Whatsapp -08105-737-966